NEOLEUKIN THERAPEUTICS INC's ticker is and the CUSIP is 64049K954. A total of 3 filers reported holding NEOLEUKIN THERAPEUTICS INC in Q3 2020. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2022 | $3,000 | -50.0% | 1,800 | +50.0% | 0.00% | – |
| Q4 2021 | $6,000 | -76.0% | 1,200 | -33.3% | 0.00% | – |
| Q4 2020 | $25,000 | -82.5% | 1,800 | -84.9% | 0.00% | – |
| Q3 2020 | $143,000 | -32.2% | 11,900 | -6.3% | 0.00% | -100.0% |
| Q2 2020 | $211,000 | +817.4% | 12,700 | +535.0% | 0.00% | – |
| Q1 2020 | $23,000 | – | 2,000 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| CONCOURSE FINANCIAL GROUP SECURITIES, INC. | 0 | $0 | 0.00% |
| GROUP ONE TRADING, L.P. | 11,900 | $143,000 | 0.00% |
| SIMPLEX TRADING, LLC | 40 | $48,000 | 0.00% |